IMMUNEBIOTICS PROBIOTIC CONSORTIA DESIGNED WITH PHARMACEUTICAL PRECISION

LIVE

Serial Number

79383166

Owner

ImmuneBiotech Medical Sweden AB

Attorney

Bradley D. Crose

Filing Date

Oct 6, 2023

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

IMMUNEBIOTICS PROBIOTIC CONSORTIA DESIGNED WITH PHARMACEUTICAL PRECISION Trademark

Serial Number: 79383166 • Registration: 7726114

IMMUNEBIOTICS PROBIOTIC CONSORTIA DESIGNED WITH PHARMACEUTICAL PRECISION is a trademark filed by ImmuneBiotech Medical Sweden AB on October 6, 2023. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals). The application is currently registered and active.

Trademark Classes

Class 1 - Chemicals

Chemical products for industry, science, photography, agriculture, horticulture and forestry

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Owner Contact Info

ImmuneBiotech Medical Sweden AB (3 trademarks)

Scheelevägen 2

Entity Type: 99

Legal Representation

Attorney of Record

Bradley D. Crose

1,287 trademarks filed View all →

Correspondence Address

Bradley D. Crose Crose Law LLC

112 Northbrooke Trace

Woodstock, GA 30188

United States

Trademark Details

Filing Date

October 6, 2023

Registration Date

March 18, 2025

Published for Opposition

January 28, 2025

Goods & Services

Bacteriological preparations, other than for medical and veterinary use; ferments for industrial purposes, probiotic bacteria for use in the manufacture of food supplements

Probiotic bacterial formulations for medical use; probiotic supplements; food supplements; bacteriological preparations for medical purposes; probiotic preparations for medical use to help maintain a natural balance of the flora of the digestive system; pharmaceutical preparations treating and preventing conditions associated with gastrointestinal disorders; dietetic preparations adapted for medical and pharmaceutical purposes, namely, probiotic bacterial and bacterial cultures.

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB

Oct 18, 2025 FINO

FINAL DISPOSITION NOTICE SENT TO IB

Sep 26, 2025 FICS

FINAL DISPOSITION PROCESSED

Sep 25, 2025 FIMP

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

Jun 18, 2025 FICR

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

May 3, 2025 OPNX

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

Apr 15, 2025 OPNS

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

Apr 15, 2025 OPNR

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Mar 18, 2025 NRCC

REGISTERED-PRINCIPAL REGISTER

Mar 18, 2025 R.PR

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Jan 28, 2025 NPUB

PUBLISHED FOR OPPOSITION

Jan 28, 2025 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Jan 22, 2025 NONP

APPROVED FOR PUB - PRINCIPAL REGISTER

Jan 6, 2025 CNSA

EXAMINER'S AMENDMENT ENTERED

Jan 6, 2025 XAEC

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Jan 6, 2025 GNEN

EXAMINERS AMENDMENT E-MAILED

Jan 6, 2025 GNEA

EXAMINERS AMENDMENT -WRITTEN

Jan 6, 2025 CNEA

TEAS/EMAIL CORRESPONDENCE ENTERED

Dec 18, 2024 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Dec 18, 2024 CRFA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Dec 18, 2024 TROA

REFUSAL PROCESSED BY IB

Jul 15, 2024 RFNT

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

Jun 26, 2024 RFCS

REFUSAL PROCESSED BY MPU

Jun 26, 2024 RFRR

ASSIGNED TO LIE

Jun 25, 2024 ALIE

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

Jun 14, 2024 RFCR

NON-FINAL ACTION WRITTEN

Jun 4, 2024 CNRT

ASSIGNED TO EXAMINER

May 27, 2024 DOCK

NEW REPRESENTATIVE AT IB RECEIVED

Feb 3, 2024 NREP

APPLICATION FILING RECEIPT MAILED

Nov 21, 2023 MAFR

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Nov 17, 2023 NWOS

SN ASSIGNED FOR SECT 66A APPL FROM IB

Nov 16, 2023 REPR

Related Trademarks

More from this Owner

IMMUNEBIOTECH

GUTMAGNIFIC

More in Same Class

PRIMX